-
Innovation Ranking
NewInnovation Ranking – SIG Combibloc Group Ltd
SIG Combibloc Group Ltd (SIG Combibloc), a subsidiary of Onex Corp, is a system supplier of carton packaging and filling machines. It develops and produces packaging material and the corresponding filling machines. It carries out the manufacturing and marketing of aseptic and non-aseptic filling of liquid food products including juices, dairy, plant-based drinks, soups, vegetables, desserts and sauces and other value-added beverages. The company also manufactures disposable, protective and flexible packaging systems such as small-size carton packages, non-carbonated beverage packages...
-
Product Insights
SIG Holstein/ Sparkasse – Lottbek Arcades Residential and Commercial Building – Schleswig-Holstein
The SIG Holstein/ Sparkasse – Lottbek Arcades Residential and Commercial Building – Schleswig-Holstein project involves the construction of the Lottbek Arcades residential and commercial building in Ammersbek, Schleswig-Holstein, Germany. Equip yourself with the essential tools needed to make informed and profitable decisions with our SIG Holstein/ Sparkasse – Lottbek Arcades Residential and Commercial Building – Schleswig-Holstein report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days...
-
Company Insights
Innovation and Patenting activity of SIG Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of SIG Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PVX-7 in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-7 in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVX-7 in Oropharyngeal Cancer Drug Details: PVX7 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PVX-7 in Human Papillomavirus (HPV) Associated Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-7 in Human Papillomavirus (HPV) Associated Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVX-7 in Human Papillomavirus (HPV) Associated Cancer Drug Details:...
-
Company Insights
Innovation and Patenting activity of SIG Combibloc Group Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of SIG Combibloc Group Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SiG-12D-LODER in Pancreatic Ductal Adenocarcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SiG-12D-LODER in Pancreatic Ductal Adenocarcinoma Drug Details: siG-12D LODER is under development for the treatment...
-
Analyst Opinions
Dairy and Dairy Alternative Demand Spaces – Top Trends and Industry Insights
This report is part of a series on the top trends and key demand spaces for consumers sectors to focus on in 2024. It explains how and why these trends are happening using GlobalData's TrendSights and demand space analytical frameworks. The report identifies the consumer sentiment, market development, innovation landscape, and brand actions happening within each trend. Top trends in dairy and alternatives for 2024 are heavily focused on concepts around health, affordability, and trust and reliability. Brands are also...
-
Thematic Analysis
Aerospace and Defense Predictions in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘Aerospace and Defense Predictions in 2024’ report will help: Analyze the major themes that will impact the defense industry in 2024. Identify the key defense challenges faced by defense forces and defense sector suppliers. Assess the investment opportunities for armed forces, suppliers, and institutional investors, across a range of different technology and industry themes. Learn about the diverse research and development programs currently being undertaken by various military organizations as well as aerospace and defense...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PVX-2 in Human Papillomavirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-2 in Human Papillomavirus Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PVX-2 in Human Papillomavirus InfectionsDrug Details:PVX-2 is under development for treatment of...